Pathogenic Signal Sequence Mutations in Progranulin Disrupt SRP Interactions Required for mRNA Stability

Publication date: 5 June 2018
Source:Cell Reports, Volume 23, Issue 10
Author(s): Emile S. Pinarbasi, Andrey L. Karamyshev, Elena B. Tikhonova, I-Hui Wu, Henry Hudson, Philip J. Thomas
Cells have evolved quality control pathways to prevent the accumulation of improperly localized proteins, which are often toxic. One of these pathways, regulation of aberrant protein production (RAPP), recognizes aberrant secretory proteins during translation and degrades the associated mRNA. Here, we demonstrate endogenous RAPP substrates. Haploinsufficiency of the secretory protein progranulin (GRN) is associated with the neurodegenerative disease frontotemporal lobar degeneration (FTLD). Our results show FTLD-associated GRN mutations W7R and A9D disrupt co-translational interaction with a targeting factor, signal recognition particle (SRP). This triggers RAPP and initiates specific mRNA degradation. Conversely, wild-type GRN and the naturally occurring polymorphism V5L GRN are efficiently expressed and secreted. Thus, RAPP plays a role in the molecular pathology of A9D GRN and W7R GRN.

Graphical abstract

Teaser

Progranulin mutations, which reduce its secretion, cause the disease FTLD (frontotemporal lobar degeneration). Here, Pinarbasi et al. show that one such mutation, A9D, prevents recruitment of the trafficking factor SRP (signal recognition particle). This triggers a quality control response, which results in degradation of A9D mRNA.


https://ift.tt/2JFKEj5